|
DZ2376A1
(fr)
*
|
1996-12-19 |
2002-12-28 |
Smithkline Beecham Plc |
Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
|
|
EP0994862B1
(en)
|
1997-07-11 |
2005-06-01 |
SmithKline Beecham plc |
Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
|
|
JP4253126B2
(ja)
|
1998-01-29 |
2009-04-08 |
アムジェン インコーポレイテッド |
Ｐｐａｒ−ガンマ調節剤
|
|
GB9803411D0
(en)
*
|
1998-02-18 |
1998-04-15 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6194410B1
(en)
*
|
1998-03-11 |
2001-02-27 |
Hoffman-La Roche Inc. |
Pyrazolopyrimidine and pyrazolines and process for preparation thereof
|
|
GB9810671D0
(en)
*
|
1998-05-18 |
1998-07-15 |
Pfizer Ltd |
Anti-pruritic agents
|
|
GB9818914D0
(en)
*
|
1998-08-28 |
1998-10-21 |
Smithkline Beecham Plc |
Use
|
|
GB9818916D0
(en)
*
|
1998-08-28 |
1998-10-21 |
Smithkline Beecham Plc |
Use
|
|
GB9820113D0
(en)
|
1998-09-15 |
1998-11-11 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US7041691B1
(en)
|
1999-06-30 |
2006-05-09 |
Amgen Inc. |
Compounds for the modulation of PPARγ activity
|
|
GB9926302D0
(en)
*
|
1999-11-05 |
2000-01-12 |
Smithkline Beecham Plc |
Novel compounds
|
|
WO2001045694A1
(en)
*
|
1999-12-21 |
2001-06-28 |
Smithkline Beecham Corporation |
Urotensin-ii receptor antagonists
|
|
SE9904723D0
(sv)
*
|
1999-12-22 |
1999-12-22 |
Carlsson A Research Ab |
New modulators of dopamine neurotransmission II
|
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
US20030171399A1
(en)
|
2000-06-28 |
2003-09-11 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
|
US6399617B1
(en)
|
2000-07-21 |
2002-06-04 |
Biovitrum Ab |
Use
|
|
US6818639B2
(en)
|
2000-07-21 |
2004-11-16 |
Biovitrum Ab |
Pharmaceutical combination formulation and method of treatment with the combination
|
|
SE0002754D0
(sv)
*
|
2000-07-21 |
2000-07-21 |
Pharmacia & Upjohn Ab |
New pharmaceutical combination formulation and method of treatment with the combination
|
|
SE0002739D0
(sv)
*
|
2000-07-21 |
2000-07-21 |
Pharmacia & Upjohn Ab |
New use
|
|
US7071220B2
(en)
|
2000-09-18 |
2006-07-04 |
Toa Eiyo Ltd. |
N-substituted benzothiophenesulfonamide derivatives
|
|
CN1245400C
(zh)
*
|
2000-09-18 |
2006-03-15 |
东亚荣养株式会社 |
N－取代苯并噻唑磺胺衍生物
|
|
US7034029B2
(en)
|
2000-11-02 |
2006-04-25 |
Wyeth |
1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
|
|
US6849644B2
(en)
|
2000-11-21 |
2005-02-01 |
Smithkline Beecham P.L.C. |
Isoquinoline derivatives useful in the treatment of CNS disorders
|
|
US7132546B2
(en)
|
2000-12-22 |
2006-11-07 |
Ishihara Sangyo Kaisha, Ltd. |
Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
|
|
EP1389194A2
(en)
*
|
2001-04-27 |
2004-02-18 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of bace
|
|
WO2002090337A1
(en)
*
|
2001-05-07 |
2002-11-14 |
Smithkline Beecham Corporation |
Sulfonamides
|
|
WO2002089793A1
(en)
*
|
2001-05-07 |
2002-11-14 |
Smithkline Beecham Corporation |
Sulfonamides
|
|
US6743796B2
(en)
|
2001-05-07 |
2004-06-01 |
Wyeth |
Piperazinyl-isatins
|
|
WO2002089785A1
(en)
*
|
2001-05-07 |
2002-11-14 |
Smithkline Beecham Corporation |
Sulfonamides
|
|
AR033879A1
(es)
*
|
2001-05-07 |
2004-01-07 |
Smithkline Beecham Corp |
Compuesto sulfonamida, composicion farmaceutica que lo comprende, su uso para preparar dicha composicion y procedimiento para la obtencion de dicho compuesto
|
|
WO2002089740A2
(en)
*
|
2001-05-07 |
2002-11-14 |
Smithkline Beecham Corporation |
Sulfonamides
|
|
GB0111186D0
(en)
*
|
2001-05-08 |
2001-06-27 |
Smithkline Beecham Plc |
Novel compounds
|
|
EP1406884A1
(en)
|
2001-05-11 |
2004-04-14 |
Biovitrum Ab |
Arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
|
|
US7718650B2
(en)
|
2001-05-11 |
2010-05-18 |
Biovitrum Ab |
Aryl sulfonamide compounds for treating obesity
|
|
RS88803A
(sr)
*
|
2001-05-11 |
2007-02-05 |
Biovitrum Ab., |
Nova jedinjenja arilsulfonamida za lečenje gojaznosti, dijabetesa tipa ii i poremećaja cns
|
|
BR0210929A
(pt)
|
2001-06-07 |
2004-06-08 |
Hoffmann La Roche |
Derivados de indol com afinidade para o receptor 5-ht6
|
|
CN1800185A
(zh)
|
2001-06-11 |
2006-07-12 |
比奥维特罗姆股份公司 |
取代的磺酰胺化合物、其制备方法及其作为治疗cns疾病、肥胖和ii型糖尿病的药物的应用
|
|
ES2268113T3
(es)
|
2001-06-15 |
2007-03-16 |
F. Hoffmann-La Roche Ag |
Derivados de 4-piperazinilindol con afinidad al receptor 5-ht6.
|
|
US6727264B1
(en)
|
2001-07-05 |
2004-04-27 |
Synaptic Pharmaceutical Corporation |
Substituted anilinic piperidines as MCH selective antagonists
|
|
EP1414442A1
(en)
*
|
2001-08-07 |
2004-05-06 |
Smithkline Beecham Plc |
3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
|
|
MXPA04001250A
(es)
|
2001-08-10 |
2004-05-27 |
Hoffmann La Roche |
Derivados de arilsulfonilo con afinidad receptora de 5-hidroxitriptamina6 (5-ht6).
|
|
TWI325317B
(en)
*
|
2001-09-05 |
2010-06-01 |
Eisai R&D Man Co Ltd |
Appetite-stimulating agents and remedies for anorexia
|
|
SE0103644D0
(sv)
*
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic isoquinoline compounds
|
|
EP1450806B1
(en)
*
|
2001-11-09 |
2009-04-29 |
Biovitrum AB (publ) |
Use of sulfonamide derivatives in the treatment of obesity or for the reduction of food intake
|
|
RS44204A
(sr)
|
2001-11-22 |
2007-06-04 |
Biovitrum Ab., |
Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1
|
|
EA200400707A1
(ru)
|
2001-11-22 |
2004-10-28 |
Биовитрум Аб |
Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
|
|
MXPA04004981A
(es)
*
|
2001-11-30 |
2004-08-11 |
Hoffmann La Roche |
Derivados de piperazina para uso como antagonistas del receptor ccr-3 en tratamiento de asma.
|
|
AU2003244452A1
(en)
*
|
2002-02-05 |
2003-09-02 |
Glaxo Group Limited |
Method of promoting neuronal growth
|
|
EP1474401A2
(en)
*
|
2002-02-05 |
2004-11-10 |
Novo Nordisk A/S |
Novel aryl- and heteroarylpiperazines
|
|
ATE323680T1
(de)
*
|
2002-02-13 |
2006-05-15 |
Glaxo Group Ltd |
7-arylsulfonamid-2,3,4,5-tetrahydro-1h- benzo¬däazepine mit 5-ht6 rezeptor affinität zur behandlung von zentralnervensystemerkrankungen
|
|
WO2003068732A2
(en)
*
|
2002-02-13 |
2003-08-21 |
Glaxo Group Limited |
Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
|
|
MXPA04007920A
(es)
*
|
2002-02-13 |
2004-11-26 |
Glaxo Group Ltd |
Derivados de bencensulfonamida como agentes antisicoticos.
|
|
RU2309154C9
(ru)
*
|
2002-03-27 |
2016-09-27 |
Глэксо Груп Лимитед |
3-фенилсульфонил-8-пиперазин-1-ил-хинолины, обладающие аффинностью к 5-нт6 рецептору, способы их получения (варианты)
|
|
US20040142948A1
(en)
*
|
2002-05-07 |
2004-07-22 |
Dashyant Dhanak |
Sulfonamides
|
|
PT1506179E
(pt)
*
|
2002-05-13 |
2006-06-30 |
Hoffmann La Roche |
Derivados de benzoxazina como moduladores de 5-ht6 e suas utilizacoes
|
|
WO2004000828A1
(en)
*
|
2002-06-20 |
2003-12-31 |
Biovitrum Ab |
New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
|
|
JP4754821B2
(ja)
*
|
2002-06-20 |
2011-08-24 |
プロキシマゲン・リミテッド |
肥満症、ｉｉ型糖尿病およびｃｎｓ障害の治療に有用な新規化合物
|
|
EP1897881A3
(en)
|
2002-06-20 |
2009-03-18 |
Biovitrum AB (publ) |
Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
|
RU2324693C2
(ru)
|
2002-10-18 |
2008-05-20 |
Ф.Хоффманн-Ля Рош Аг |
4-пиперазинилбензолсульфонилиндолы, характеризующиеся сродством к рецептору 5-нт6
|
|
AU2003295408A1
(en)
*
|
2002-11-06 |
2004-06-03 |
Smithkline Beecham Corporation |
Sulfonamides
|
|
AU2003291262A1
(en)
*
|
2002-11-06 |
2004-06-03 |
Smithkline Beecham Corporation |
Sulfonamides
|
|
MXPA05007485A
(es)
|
2003-01-14 |
2006-01-30 |
Arena Pharm Inc |
Derivados de arilo y heteroarilo 1,2,3-trisubstituidos como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con ello tales como diabetes e hiperglicemia.
|
|
US7153858B2
(en)
|
2003-01-31 |
2006-12-26 |
Epix Delaware, Inc. |
Arylpiperazinyl compounds
|
|
US20060257613A1
(en)
*
|
2003-02-13 |
2006-11-16 |
Horst Berneth |
Metal complexes as light-absorbing compounds in the information layer of optical data carriers
|
|
US7319111B2
(en)
*
|
2003-02-20 |
2008-01-15 |
Encysive Pharmaceuticals, Inc. |
Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists
|
|
TWI289141B
(en)
*
|
2003-03-11 |
2007-11-01 |
Hoffmann La Roche F. Ag. |
Quinolinone derivatives and uses thereof
|
|
US7262197B2
(en)
*
|
2003-03-31 |
2007-08-28 |
Janssen Pharmaceutica, N.V |
Phospholipase C inhibitors for use in treating inflammatory disorders
|
|
US6946466B2
(en)
*
|
2003-04-10 |
2005-09-20 |
Schering Ag |
Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
|
|
US20040204422A1
(en)
*
|
2003-04-14 |
2004-10-14 |
Abbott Gmbh & Co. Kg. |
N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
|
|
DE602004000260T2
(de)
|
2003-07-22 |
2006-08-24 |
Arena Pharmaceuticals, Inc., San Diego |
Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
|
|
GB0320320D0
(en)
*
|
2003-08-29 |
2003-10-01 |
Glaxo Group Ltd |
Novel compounds
|
|
US7223761B2
(en)
|
2003-10-03 |
2007-05-29 |
Amgen Inc. |
Salts and polymorphs of a potent antidiabetic compound
|
|
AU2004299438A1
(en)
*
|
2003-12-19 |
2005-06-30 |
Biovitrum Ab |
Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-HT6 receptor-related disorder
|
|
SE0303480D0
(sv)
*
|
2003-12-19 |
2003-12-19 |
Biovitrum Ab |
Benzofuranes
|
|
PE20060574A1
(es)
*
|
2004-07-28 |
2006-06-24 |
Glaxo Group Ltd |
Derivados de arilpiperazina sulfonamida como agonistas de los receptores de secretagogos de la hormona del crecimiento (ghs)
|
|
CN102114244A
(zh)
*
|
2004-09-30 |
2011-07-06 |
弗·哈夫曼-拉罗切有限公司 |
治疗认知障碍的组合物和方法
|
|
EP1812389B1
(en)
|
2004-10-14 |
2011-08-17 |
Abbott GmbH & Co. KG |
Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
|
|
CA2583983C
(en)
*
|
2004-10-14 |
2013-07-16 |
Abbott Gmbh & Co. Kg |
Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
|
|
WO2006062481A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Biovitrum Ab |
New benzofuran derivatives and their use in the treatment of obesity, type ii diabetes and cns disorders .
|
|
EP1676841A1
(en)
*
|
2004-12-30 |
2006-07-05 |
Esteve Laboratorios Dr. Esteve S.A. |
Substitited indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their prepartion and use in medicaments
|
|
KR100931928B1
(ko)
*
|
2005-01-12 |
2009-12-15 |
인제대학교 산학협력단 |
P25/cdk5 저해 화합물을 포함하는 퇴행성 뇌질환의 예방 및치료용 약학 조성물
|
|
MX2007015675A
(es)
|
2005-07-04 |
2008-02-20 |
Novo Nordisk As |
Antagonistas del receptor de histamina h3.
|
|
BRPI0520579B8
(pt)
|
2005-08-12 |
2021-05-25 |
Suven Life Sciences Ltd |
composto, processo para a preparação de um composto e composição farmacêutica
|
|
KR101250820B1
(ko)
|
2005-08-16 |
2013-04-04 |
수벤 라이프 사이언시스 리미티드 |
개선된 로사르탄 제조 방법
|
|
EP1976495A2
(en)
*
|
2006-01-06 |
2008-10-08 |
Aarhus Universitet |
Compounds acting on the serotonin transporter
|
|
PE20080176A1
(es)
|
2006-03-31 |
2008-04-25 |
Glaxo Group Ltd |
Compuestos de arilpiperazina sulfonamida como agonista de los receptores de secretagogos de la hormona de crecimiento (ghs)
|
|
WO2007118900A1
(en)
|
2006-04-19 |
2007-10-25 |
Abbott Gmbh & Co. Kg |
Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
|
|
BRPI0710177A2
(pt)
*
|
2006-04-19 |
2012-05-29 |
Abbott Gmbh & Co Kg |
arilsulfonas heterocìclicas adequadas para tratar distúrbios que respondem à modulação do receptor 5ht6 de serotonina
|
|
EP2038256A1
(en)
|
2006-05-23 |
2009-03-25 |
TransTech Pharma, Inc |
6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ']-bipyridine and its use as a medicament
|
|
EP2402324A1
(en)
|
2006-05-29 |
2012-01-04 |
High Point Pharmaceuticals, LLC |
Benzodioxolylcyclopropylpiperazinylpyridazines
|
|
US7906555B2
(en)
|
2006-10-26 |
2011-03-15 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
|
|
MX2009006077A
(es)
|
2007-01-08 |
2009-06-17 |
Suven Life Sciences Ltd |
Compuestos de 5-(heterociclil)alquil-n-(arilsulfonil)indol y su uso como ligandos de la 5-hidroxitriptamina6.
|
|
BRPI0806542A2
(pt)
|
2007-01-10 |
2014-04-22 |
Hoffmann La Roche |
Derivados de sulfonamida como inibidores de quimase
|
|
US8507469B2
(en)
|
2007-03-23 |
2013-08-13 |
Abbott Gmbh & Co. Kg |
Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
EA016594B1
(ru)
|
2007-05-03 |
2012-06-29 |
Сувен Лайф Сайенсиз Лимитед |
Производные 1-(аминоалкоксиарилсульфонил)индола в качестве 5-нтлигандов
|
|
EP2014656A3
(en)
|
2007-06-11 |
2011-08-24 |
High Point Pharmaceuticals, LLC |
New heteocyclic h3 antagonists
|
|
DE602007012683D1
(de)
*
|
2007-07-19 |
2011-04-07 |
Esteve Labor Dr |
Substituierte Tetrahydro-Chinolinsulfonamidverbindungen, ihre Herstellung und ihre Verwendung als Medikamente
|
|
US7964627B2
(en)
|
2007-10-26 |
2011-06-21 |
Suven Life Sciences Limited |
Amino arylsulfonamide compounds and their use as 5-HT6 ligands
|
|
PA8802201A1
(es)
*
|
2007-11-02 |
2009-06-23 |
Abbott Gmbh & Co Kg |
Compuestos de bencensulfonalida apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6
|
|
EP2508177A1
(en)
|
2007-12-12 |
2012-10-10 |
Glaxo Group Limited |
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
|
|
US20110021538A1
(en)
|
2008-04-02 |
2011-01-27 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
EP2288345B1
(en)
|
2008-04-18 |
2015-06-10 |
University College Dublin National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
|
UA103319C2
(en)
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
|
CN102089278A
(zh)
*
|
2008-06-11 |
2011-06-08 |
Irm责任有限公司 |
用于治疗疟疾的化合物和组合物
|
|
US8318725B2
(en)
|
2008-09-17 |
2012-11-27 |
Suven Life Sciences Limited |
Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands
|
|
CA2737282C
(en)
*
|
2008-09-17 |
2014-03-25 |
Suven Life Sciences Limited |
Aryl sulfonamide amine compounds and their use as 5-ht6 ligands
|
|
US9126946B2
(en)
|
2008-10-28 |
2015-09-08 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
|
|
UA100192C2
(en)
|
2008-11-11 |
2012-11-26 |
УАЙТ ЭлЭлСи |
1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
|
|
KR101073703B1
(ko)
|
2009-04-07 |
2011-10-14 |
한국화학연구원 |
피페라진 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 중추신경계 질환의 예방 또는 치료용 약학적 조성물
|
|
US8362010B2
(en)
|
2009-04-30 |
2013-01-29 |
Abbott Gmbh & Co. Kg |
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
US8343959B2
(en)
|
2009-04-30 |
2013-01-01 |
Abbott Gmbh & Co. Kg |
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
AU2010243585B2
(en)
|
2009-04-30 |
2014-08-07 |
AbbVie Deutschland GmbH & Co. KG |
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
WO2010125135A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Abbott Gmbh & Co. Kg |
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
|
|
JP5628937B2
(ja)
|
2010-01-05 |
2014-11-19 |
スベン ライフ サイエンシズ リミティド |
５−ｈｔ６受容体リガンドとしてのスルホン化合物
|
|
EP3323818A1
(en)
|
2010-09-22 |
2018-05-23 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
WO2012059431A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
|
|
WO2012059432A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
|
|
ES2413911B1
(es)
*
|
2011-12-15 |
2014-05-14 |
Universidad De Zaragoza |
Agente inhibidor de la agregación del peptido beta amiloide.
|
|
JP2015512383A
(ja)
|
2012-03-20 |
2015-04-27 |
アダムド エスピー．ゼット オー．オー．Ａｄａｍｅｄ Ｓｐ．Ｚ Ｏ．Ｏ． |
Ｃｎｓ疾患の処置のためのベンジルアミンのスルホンアミド誘導体
|
|
MX394360B
(es)
|
2013-03-14 |
2025-03-24 |
Sumitomo Pharma Oncology Inc |
Inhibidores de jak2 y alk2 y metodos para su uso.
|
|
CN105531272B
(zh)
|
2013-07-25 |
2017-12-22 |
雅盖隆大学 |
作为5‑ht6拮抗剂的吡咯并喹啉衍生物、其制备方法和用途
|
|
US9840482B2
(en)
|
2014-04-19 |
2017-12-12 |
Sunshine Lake Pharma Co., Ltd. |
Sulfonamide derivatives and pharmaceutical applications thereof
|
|
CN105367472B
(zh)
*
|
2014-08-12 |
2020-04-21 |
广东东阳光药业有限公司 |
吲哚啉类衍生物及其在药物上的应用
|
|
CN105367473B
(zh)
*
|
2014-08-12 |
2020-02-11 |
广东东阳光药业有限公司 |
吲哚啉类衍生物及其在药物上的应用
|
|
PL3242666T3
(pl)
|
2015-01-06 |
2025-02-17 |
Arena Pharmaceuticals, Inc. |
Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1
|
|
US10022355B2
(en)
|
2015-06-12 |
2018-07-17 |
Axovant Sciences Gmbh |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder
|
|
BR112017027656B1
(pt)
|
2015-06-22 |
2023-12-05 |
Arena Pharmaceuticals, Inc. |
Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
|
|
BR112018000728A2
(pt)
|
2015-07-15 |
2018-09-04 |
Axovant Sciences Gmbh |
resumo método para a profilaxia e/ou tratamento de alucinações visuais em um sujeito com necessidade do mesmo
|
|
CN108926565A
(zh)
*
|
2017-05-26 |
2018-12-04 |
中国科学院上海生命科学研究院 |
五羟色胺受体亚型6小分子激活剂及拮抗剂在防治阿尔茨海默症中的应用
|
|
WO2019180176A1
(en)
|
2018-03-21 |
2019-09-26 |
Spherium Biomed, S.L. |
Composition for the treatment of schizophrenia and/or psychosis
|
|
CA3102136A1
(en)
|
2018-06-06 |
2019-12-12 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|
|
AU2019310590A1
(en)
|
2018-07-26 |
2021-01-14 |
Sumitomo Pharma Oncology, Inc. |
Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same
|